Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Microenvironment

Constitution and telomere dynamics of bone marrow stromal cells in patients undergoing allogeneic bone marrow transplantation

Summary:

We evaluated the genotypic origin of mesenchymal stem cells (MSC) following sex-mismatched allogeneic bone marrow transplantation (BMT), and investigated the telomere dynamics in MSC in normal individuals and patients after BMT. The study population consisted of 11 patients with hematologic disorders who showed complete chimerism after BMT. Telomere length was measured in MSC using Southern blotting analysis in eight patients and 18 healthy subjects as a control group. Following culture, MSC were identified by the expression of SH2 and SH4, and lack of CD14, CD34, and CD45. All MSC showed the recipient genotype, based on the results of fluorescent in situ hybridization analysis using X-chromosome satellite probes or microsatellite DNA polymorphism analysis. The mean telomere length in MSC from normal controls was 7.2±0.53 kb (range, 6.12–7.78), and progressive telomere shortening was seen with age. There was no significant difference in MSC telomere length between the BMT group and age-matched controls. This study confirmed that the MSC isolated from the recipients of allogeneic BMT did not have the donor genotype, despite complete chimerism. Moreover, MSC were demonstrated to show progressive loss of telomere length with age, but the telomeres in MSC were not affected by BMT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Majumdar MK, Thiede MA, Mosca JD et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998; 176: 57–66.

    Article  CAS  Google Scholar 

  2. Deans RJ, Moseley AB . Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000; 28: 875–884.

    Article  CAS  Google Scholar 

  3. Chamberlin W, Barone J, Kedo A, Fried W . Lack of recovery of murine hematopoietic stromal cells after irradiation-induced damage. Blood 1974; 44: 385–392.

    CAS  PubMed  Google Scholar 

  4. Fried W, Chamberlin W, Kedo A, Barone J . Effects of radiation on hematopoietic stroma. Exp Hematol 1976; 4: 310–314.

    CAS  PubMed  Google Scholar 

  5. Carlo-Stella C, Tabilio A, Regazzi E et al. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors. Bone Marrow Transplant 1997; 20: 465–471.

    Article  CAS  Google Scholar 

  6. Domenech J, Roingeard F, Binet C . The mechanisms involved in the impairment of hematopoiesis after autologous bone marrow transplantation. Leukemia Lymphoma 1997; 24: 239–256.

    Article  CAS  Google Scholar 

  7. O'Flaherty E, Sparrow R, Szer J . Bone marrow stromal function from patients after bone marrow transplantation. Bone Marrow Transplant 1995; 15: 207–212.

    CAS  Google Scholar 

  8. Galotto M, Berisso G, Delfino L et al. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol 1999; 27: 1460–1466.

    Article  CAS  Google Scholar 

  9. Devine SM, Hoffman R . Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Curr Opin Hematol 2000; 7: 358–363.

    Article  CAS  Google Scholar 

  10. Koc ON, Lazarus HM . Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant 2001; 27: 235–239.

    Article  CAS  Google Scholar 

  11. Simmons PJ, Przepiorka D, Thomas ED, Torok-Storb B . Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature 1987; 328: 429–432.

    Article  CAS  Google Scholar 

  12. Koc ON, Peters C, Aubourg P et al. Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. Exp Hematol 1999; 27: 1675–1681.

    Article  CAS  Google Scholar 

  13. Awaya N, Rupert K, Bryant E, Torok-Storb B . Failure of adult marrow-derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation. Exp Hematol 2002; 30: 937–942.

    Article  Google Scholar 

  14. Bianco P, Gehron Robey P . Marrow stromal stem cells. J Clin Invest 2000; 105: 1663–1668.

    Article  CAS  Google Scholar 

  15. Horwitz EM, Prockop DJ, Fitzpatrick LA et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309–313.

    Article  CAS  Google Scholar 

  16. Blackburn EH . Structure and function of telomeres. Nature 1991; 350: 569–573.

    Article  CAS  Google Scholar 

  17. Zakian VA . Telomeres: beginning to understand the end. Science 1995; 270: 1601–1607.

    Article  CAS  Google Scholar 

  18. Moyzis RK, Buckingham JM, Cram LS et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988; 85: 6622–6626.

    Article  CAS  Google Scholar 

  19. Blackburn EH . Telomeres: no end in sight. Cell 1994; 77: 621–623.

    Article  CAS  Google Scholar 

  20. Vaziri H, Dragowska W, Allsopp RC et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994; 91: 9857–9860.

    Article  CAS  Google Scholar 

  21. Shay JW . Accelerated telomere shortening in bone-marrow recipients. Lancet 1998; 351: 153–154.

    Article  CAS  Google Scholar 

  22. Wynn RF, Cross MA, Hatton C et al. Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet 1998; 351: 178–181.

    Article  CAS  Google Scholar 

  23. Lee J, Kook H, Chung I et al. Telomere length changes in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 1999; 24: 411–415.

    Article  CAS  Google Scholar 

  24. Rufer N, Brummendorf TH, Chapuis B et al. Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation. Blood 2001; 97: 575–577.

    Article  CAS  Google Scholar 

  25. Lee JJ, Kook H, Chung IJ et al. Telomere length changes in patients with aplastic anaemia. Br J Haematol 2001; 112: 1025–1030.

    Article  CAS  Google Scholar 

  26. Laver J, Jhanwar SC, O'Reilly RJ, Castro-Malaspina H . Host origin of the human hematopoietic microenvironment following allogeneic bone marrow transplantation. Blood 1987; 70: 1966–1968.

    CAS  PubMed  Google Scholar 

  27. Agematsu K, Nakahori Y . Recipient origin of bone marrow-derived fibroblastic stromal cells during all periods following bone marrow transplantation in humans. Br J Haematol 1991; 79: 359–365.

    Article  CAS  Google Scholar 

  28. Gordon MY . The origin of stromal cells in patients treated by bone marrow transplantation. Bone Marrow Transplant 1988; 3: 247–251.

    CAS  PubMed  Google Scholar 

  29. Santucci MA, Trabetti E, Martinelli G et al. Host origin of bone marrow fibroblasts following allogeneic bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant 1992; 10: 255–259.

    CAS  PubMed  Google Scholar 

  30. Klyushnenkova E, Shustova V, Mosca J et al. Human mesenchymal stem cells induce unresponsiveness in preactivated but not naive alloantigen-specific T cells. Exp Hematol 1999; 27: a122.

    Google Scholar 

  31. Koc ON, Gerson SL, Cooper BW et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000; 18: 307–316.

    Article  CAS  Google Scholar 

  32. Horwitz E, Gordon P, Koo W et al. Transplanted gene-marked marrow mesenchymal stem cells engraft and benefit children with severe osteogenesis imperfecta: a pilot trial for cell and gene therapy of mesenchymal disorders. Mol Ther 2000; 1: s279.

    Google Scholar 

  33. Koc ON, Day J, Nieder M et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002; 30: 215–222.

    Article  CAS  Google Scholar 

  34. Iwama H, Ohyashiki K, Ohyashiki JH et al. Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals. Hum Genet 1998; 102: 397–402.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (01-PJ10-PG6-01GN16-0005).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H-J Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, JJ., Nam, CE., Kook, H. et al. Constitution and telomere dynamics of bone marrow stromal cells in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 32, 947–952 (2003). https://doi.org/10.1038/sj.bmt.1704253

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704253

Keywords

This article is cited by

Search

Quick links